The Oncology Institute Announces Fourth Quarter and Full Year 2025 Earnings Release Date and Conference Call

Rhea-AI Summary

The Oncology Institute (NASDAQ: TOI) will release fourth quarter and full year 2025 financial results on Thursday, March 12, 2026, followed by a conference call the same day at 5:00 p.m. ET. Investors can join via phone or webcast.

A replay will be available two hours after the call through Thursday, March 19, 2026 using the provided passcode; international dial-in and webcast details are available on the investor relations site.

CERRITOS, Calif., Feb. 26, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (“TOI”) (NASDAQ: TOI)  a pioneer in value-based community oncology care, today announced that the company will release its fourth quarter and full year 2025 financial results on Thursday, March 12, 2026, to be followed by a conference call the same day at 5:00 p.m. (Eastern Time).

The conference call can be accessed live over the phone by dialing 1-877-407-0789 or for international callers, 1-201-689-8562. A replay will be available two hours after the call and can be accessed by dialing 1-844-512-2921, or for international callers, 1-412-317-6671. The passcode for the live call and the replay is 13758646. The replay will be available until Thursday March 19, 2026.

Interested investors and other parties may also listen to a simultaneous webcast of the conference call by logging onto the Investor Relations section of the Company’s website at https://investors.theoncologyinstitute.com/.

About The Oncology Institute

Founded in 2007, The Oncology Institute (NASDAQ: TOI) is advancing oncology by delivering highly specialized, value-based cancer care in the community setting. TOI offers cutting-edge, evidence-based cancer care to a population of approximately 1.9 million patients, including clinical trials, transfusions, and other care delivery models traditionally associated with the most advanced care delivery organizations. With over 180 employed and affiliate clinicians and over 100 clinics and affiliate locations of care across five states and growing, TOI is changing oncology for the better.

Contacts

Media

The Oncology Institute, Inc.
marketing@theoncologyinstitute.com

Investors

ICR Healthcare
TOI@icrhealthcare.com

FAQ

When will TOI (NASDAQ: TOI) release Q4 and full-year 2025 results?

TOI will release fourth quarter and full year 2025 results on March 12, 2026. According to the company, the release is followed by a conference call the same day at 5:00 p.m. ET for investors and analysts.

How can investors join The Oncology Institute (TOI) conference call on March 12, 2026?

Investors can join the conference call by phone or webcast on March 12, 2026 at 5:00 p.m. ET. According to the company, live dial-ins and a simultaneous webcast are available via the investor relations website.

What are the dial-in numbers and passcode for the TOI (NASDAQ: TOI) earnings call?

The live call numbers are 1-877-407-0789 (US) and 1-201-689-8562 (international); passcode 13758646. According to the company, the same passcode applies to the live call and the replay.

When and how can I access the replay of The Oncology Institute (TOI) March 12, 2026 call?

A replay will be available two hours after the March 12 call and accessible until March 19, 2026. According to the company, dial-in replay numbers and passcode are provided, and the webcast replay is on the investor site.

Where is The Oncology Institute (TOI) hosting the webcast for the March 12, 2026 earnings call?

The simultaneous webcast will be hosted on the company’s Investor Relations website at the specified URL. According to the company, listeners can log onto the Investor Relations section to access the live webcast and replay.